Showing results (1791-1800 of 2,107) with videos related to
Sort By:
Pageof 211
CNS Drugs|July 17, 2016
New Pharmacological Agents to Aid Smoking Cessation and Tobacco Harm Reduction: What Has Been Investigated, and What Is in the Pipeline?Emma Beard, Lion Shahab, Damian M Cummings, et al.CNS Drugs|July 21, 2016
Medication Adherence in Patients with Bipolar Disorder: A Comprehensive ReviewJennifer B Levin, Anna Krivenko, Molly Howland, et al.CNS Drugs|May 1, 2020
A Phase II Randomized Trial to Explore the Potential for Pharmacokinetic Drug-Drug Interactions with Stiripentol or Valproate when Combined with Cannabidiol in Patients with EpilepsyElinor Ben-Menachem, Boudewijn Gunning, Carmen María Arenas Cabrera, et al.CNS Drugs|April 23, 2020
Tapering with Pharmaceutical GHB or Benzodiazepines for Detoxification in GHB-Dependent Patients: A Matched-Subject Observational Study of Treatment-as-Usual in Belgium and The NetherlandsHarmen Beurmanjer, J J Luykx, B De Wilde, et al.CNS Drugs|May 29, 2020
Newer Formulations of Risperidone: Role in the Management of Psychotic DisordersIvana Clark, David TaylorCNS Drugs|July 21, 2001
Occupational exposure to volatile anaesthetics: epidemiology and approaches to reducing the problemC Byhahn, H J Wilke, K WestpphalCNS Drugs|July 21, 2001
Sleep disorders in patients with Parkinson's disease: epidemiology and managementJ P Larsen, E TandbergCNS Drugs|July 21, 2001
Oxidative damage and schizophrenia: an overview of the evidence and its therapeutic implicationsJ K Yao, R D Reddy, D P van KammenCNS Drugs|July 20, 2001
Clinically significant drug interactions with agents specific for migraine attacksM J EadiePageof 211